ONCOTHYREON INC. AMENDMENT TO GARY CHRISTIANSON OFFER LETTEROffer Letter • March 30th, 2009 • Oncothyreon Inc. • Services-commercial physical & biological research • Washington
This amendment (the “Amendment”) is made by and between Gary Christianson (“Executive”) and Oncothyreon Inc. (formerly Biomira Inc.), a Delaware corporation (the “Company” and together with the Executive hereinafter collectively referred to as the “Parties”) on December 31, 2008.
ASSET PURCHASE AGREEMENTAsset Purchase Agreement • March 30th, 2009 • Oncothyreon Inc. • Services-commercial physical & biological research • Alberta
(Oncothyreon Canada, Biomira Management and Oncothyreon Parent hereinafter collectively referred to as “Oncothyreon”)
ONCOTHYREON INC. NOTE AMENDMENT AGREEMENTNote Amendment Agreement • March 30th, 2009 • Oncothyreon Inc. • Services-commercial physical & biological research
This Note Amendment Agreement (this “Agreement”) is made as of this 20th day of April 2008, by and between Oncothyreon Inc., formerly known as Biomira Inc., (the “Company”) and Jeffrey Millard (“Employee”).
ONCOTHYREON INC. NOTE AMENDMENT AGREEMENTNote Amendment Agreement • March 30th, 2009 • Oncothyreon Inc. • Services-commercial physical & biological research
This Note Amendment Agreement (this “Agreement”) is made as of this 20th day of April 2008, by and between Oncothyreon Inc., formerly known as Biomira Inc., (the “Company”) and Linda Pestano (“Employee”).
ONCOTHYREON INC. AMENDMENT TO ROBERT KIRKMAN OFFER LETTEROffer Letter • March 30th, 2009 • Oncothyreon Inc. • Services-commercial physical & biological research • Washington
This amendment (the “Amendment”) is made by and between Robert Kirkman (“Executive”) and Oncothyreon Inc. (formerly Biomira Inc.), a Delaware corporation (the “Company” and together with the Executive hereinafter collectively referred to as the “Parties”) on December 31, 2008.
AMENDED AND RESTATED LICENSE AGREEMENT (2008)License Agreement • March 30th, 2009 • Oncothyreon Inc. • Services-commercial physical & biological research • England
This amended and restated agreement is between Biomira Management Inc., a Delaware corporation with offices located at Seattle, Washington (“ONCOTHYREON”), and Merck KGaA, a German corporation with offices located at Darmstadt, Germany (“MERCK”) and is effective as of December 18, 2008.
